A research team from the Institute of Neurosciences of the University of Barcelona (UBneuro) and the Faculty of Medicine and Health Sciences at the University of Barcelona has developed a… Read More from UBneuro researchers Unveil Stem Cell–based Strategy Enhancing Brain Regeneration and Plasticity
Cryo-EM structure of the AMPA-type glutamate receptor GluA4 in complex with its auxiliary protein TARP-γ2. The study reveals how this interaction regulates receptor gating and desensitization, providing new insights into synaptic transmission. Image adapted from Soto et al., Nature Structural & Molecular Biology (2025). DOI: 10.1038/s41594-025-01666-7… Read More from Researchers uncover molecular mechanisms of GluA4-containing AMPA receptors
Dr. Mercè Pallàs, leading research for improved autism treatment at the University of Barcelona, supported by CaixaImpulse Innovation 2025…. Read More from Mercè Pallàs receives CaixaImpulse support to develop a novel drug for autism therapy
An international study published in the journal Nature Medicine casts doubt on the widespread belief that higher levels of formal education directly protect against cognitive decline and brain ageing. The study analysed… Read More from A higher level of education does not reduce cognitive decline in ageing
A research team from the Faculty of Psychology at the University of Barcelona, the UB Institute of Neurosciences (UBneuro) and the Bellvitge Biomedical Research Institute (IDIBELL) has identified, for the… Read More from UB-IDIBELL study identifies key neurophysiological mechanism in human memory formation
A research team at the University of Barcelona has shown how artificial intelligence (AI) models can detect personality traits from written texts, and for the first time has managed to… Read More from UBneuro study reveals how AI models identify personality traits from written texts
Researchers at UBneuro just published in “Alzheimer’s & Dementia”, the main journal of the american Alzheimer’s Association,a study that investigated the role of astrocytic RTP801 in cognitive decline in a… Read More from UBneuro Researchers Uncover the Impact of Astrocytic RTP801 on Alzheimer’s Disease Progression
A study published in the Journal of Medicinal Chemistry presents a new family of candidate compounds for the treatment of Alzheimer’s disease and pain, which have shown promising effects in animal models…. Read More from Researchers develop a potential new drug for Alzheimer’s and pain treatment
Photoactivable drugs are activated when irradiated by a beam of light — via an optical fibre — thus generating a controlled and local therapeutic effect on target tissues. Now, a… Read More from Design of the first remote photoactivation device
On April 7th, at the Faculty of Psychology at the University of Barcelona we inaugurated the highly anticipated Cognitive Neuroscience Unit, a groundbreaking step in the application of innovative technology… Read More from A New Era in Neuroscience: Launch of the Cognitive Neuroscience Unit
Alzheimer’s disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited efficacy and only in mild stages of the disease. A team from… Read More from UBneuro researchers develop a new compound with therapeutic potential against Alzheimer’s disease
How does a tennis player like Carlos Alcaraz decide where to run to return Novak Djokovic’s ball by just looking at the ball’s initial position? These behaviours, so common in… Read More from An UBneuro study designs a new model that accurately predicts the movement of elite athletes to catch the ball in parabolic flight